New preclinical results demonstrate the potential of ARD-201 in enhanced glucose control, along with preservation of lean mass, underscoring its opportunity in addressing key challenges in today’s ...

Q3 2025 Earnings Call November 4, 2025 8:30 AM ESTCompany ParticipantsStephanie Amaimo - Vice President of Investor ...

Background Major depressive disorder (MDD) is a severe mental health condition that profoundly affects both psychological and physical well-being. Growing evidence indicates that targeting the ...

This news release constitutes a 'Designated News Release' incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, ...